Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health and Care Research (NIHR) has awarded the Modernising Medical Microbiology consortium £11 million to address major public health threat, antimicrobial resistance. The Oxford Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, hosted by the Nuffield Department of Medicine since 2014, is one of 13 HPRUs funded by NIHR as part of an £80 million funding boost.

AMR scientist in a lab

The award will allow the HPRU in Healthcare Associated Infections and Antimicrobial Resistance, a multi-disciplinary partnership between the UK Health Security Agency and the University of Oxford, to continue to find original and creative ways to combat the major threats posed by healthcare-associated infections and antimicrobial resistance, in collaboration with representatives of patients, the public, and the NHS. The HPRU will build on world-leading research, systems, and tools developed over 10 years of working between partner universities and the UK Health Security Agency.

From 1 April 2025, the HPRU will collaborate with Universities of Leeds, Bristol, Nottingham and Manchester, bringing together world class researchers together to:

  • Work out how information collected every time people go to hospital or their GP can be used to track infections and antimicrobial resistance.
  • Understand better who is most affected by healthcare associated infections and antimicrobial resistance and why.
  • Explore how to use antibiotics better outside of hospitals.
  • Improve how we manage one of the most challenging and resistant types of infection, ‘Gram-negative’ infections.

Professor Sarah Walker, Professor of Medical Statistics and Epidemiology in the Experimental Medicine Division and Director of the HPRU in Healthcare Associated Infections and Antimicrobial Resistance, said: ‘We are excited to have this opportunity to build on our successful track record of collaborative working to drive changes in how we identify, monitor, investigate and ultimately reduce the impact of healthcare associated infections and antimicrobial resistance over the next 5 years, whilst also training the next generation of public-health focussed researchers.’

Similar stories

Dr Xin Hui Chan awarded BIA Barnett Christie Lecture

Dr Xin Hui Chan has won the competitive 2024 Barnett Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled ‘Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician’.